CPG-10104
N/A
Report date: 2024/03/30 20:00:47
Base Information
Drug NameCPG-10104
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesLeiden University Medical CenterGeorge Washington University (The)Amsterdam Institute For Global Health And Development
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A